Skip to main content
Glama

Data Lv

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark it read-only and idempotent, and the description adds substantial behavioral detail beyond that: graceful degradation of LEI/FIGI enrichment, cascade through multiple lookup endpoints, explicit `unresolved` reporting rather than omission, and ambiguity handling via `figi_candidates`. This gives the agent a strong model of tool behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and every clause carries information, but it is structured as one long paragraph with many nested parentheticals. It is front-loaded with the core intent and 'Use FIRST' guidance, and the length is justified by the tool's complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description must explain return semantics, and it does: named identifiers per source, `figi_candidates` for ambiguity, `unresolved` for failures, and the RxNorm citation path. It also covers degradation behavior and supported lookup routes, leaving no critical call-time unknown for an agent.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even with 100% schema coverage, the description enriches both parameters considerably. It explains what each supported type resolves to, lists accepted value forms for `value`, and gives concrete examples plus an anti-example for bond issuer names, teaching correct invocation syntax beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a precise operation: resolving a user-spoken NAME to canonical/official identifiers, with concrete examples of user queries. It explicitly differentiates from sibling tools by noting these are identifiers 'other tools require as input' and names entity_profile-style follow-ups as downstream uses.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit direction: 'Use FIRST whenever you have a name but need an ID.' It also specifies input formats and cautions against including trailing security-class words. However, it does not name alternatives to avoid or describe when not to use it beyond the general 'when you need an ID' rule.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Data Lv toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.3/5.0
Disambiguation5/5

Each tool targets a distinct purpose: data lookup (ask_pipeworx vs deep_research), entity profiles, comparisons, memory, monitoring, and prediction market analysis. Overlaps are minimal and mitigated by explicit usage guidance (e.g., ask_pipeworx vs. ask_pipeworx_grounded vs. deep_research).

Naming Consistency5/5

All tools use descriptive snake_case names following a verb_noun or verb_preposition pattern (e.g., entity_profile, resolve_entity, scan_dependency). The naming is predictable and internally consistent, making it easy for an agent to infer tool purposes.

Tool Count3/5

33 tools is on the high end for typical MCP servers. However, the server covers an exceptionally broad domain (structured data across SEC, FDA, FRED, weather, news, crypto, etc.) and includes meta-tools, monitoring, and memory. The count is justified but may feel excessive for many use cases.

Completeness5/5

The tool surface covers the full lifecycle of data access and analysis: discovery (discover_tools, suggest_questions), retrieval (ask_pipeworx, entity_profile), comparison, claim validation, monitoring, memory, and feedback. There are no obvious gaps for the declared domain, and a feedback tool is provided for missing functionality.

Resources